InsiderSignal.AI

InsiderSignal.ai

NEO - Neogenomics Inc

Insider Purchase by Sherman Jeffrey Scott (CFO)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Sherman Jeffrey Scott, serving as CFO at Neogenomics Inc (NEO), purchased 20,000 shares at $5.62 per share, for a total transaction value of $112,322.00. Following this transaction, Sherman Jeffrey Scott now holds 188,332 shares of NEO.

This purchase represents a 12.00% increase in Sherman Jeffrey Scott's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 6, 2025, meaning the disclosure happened on the same day as the trade.

Neogenomics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Sherman Jeffrey Scott

CFO

Jeffrey S. Sherman (also referred to as Jeff Sherman or Sherman Jeffrey Scott) is a seasoned healthcare finance executive with over 32 years of experience.[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/229/neogenomics-announces-chief-financial-officer-transition) He holds a bachelor's degree in Finance/Accounting from the University of Colorado, Boulder, and an MBA from the University of Southern California.[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/229/neogenomics-announces-chief-financial-officer-transition) Sherman joined NeoGenomics, Inc. (NASDAQ: NEO) as Chief Financial Officer (CFO) on December 7, 2022, succeeding William Bonello.[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/229/neogenomics-announces-chief-financial-officer-transition) His career highlights include serving as CFO of Privia Health Group, Inc. (NASDAQ: PRVA); Executive Vice President, CFO, and Treasurer at HMS (2014-2021), where he contributed to improved performance and a $3.4 billion sale to Veritas-backed Gainwell Technologies; Executive Vice President and CFO at AccentCare (2013-2014); and Executive Vice President and CFO at Lifepoint Hospitals, Inc. (2009-2013), along with senior roles at Tenet Healthcare Corporation.[[2]](https://ir.neogenomics.com/news-events/press-releases/detail/229/neogenomics-announces-chief-financial-officer-transition) At NeoGenomics, he is retiring effective April 14, 2026, transitioning to Executive Vice President on March 2, 2026, to support the incoming CFO, Abhishek Jain.[[1]](https://www.marketscreener.com/news/neogenomics-inc-announces-chief-financial-officer-changes-ce7e58dad08bf320)[[3]](https://longbridge.com/en/news/272266906)[[4]](https://www.tradingview.com/news/tradingview:1809a43ace885:0-neogenomics-announces-cfo-transition-and-appointment/)

View full insider profile →

Trade Price

$5.62

Quantity

20,000

Total Value

$112,322.00

Shares Owned

188,332

Trade Date

Wednesday, August 6, 2025

200 days ago

SEC Filing Date

Wednesday, August 6, 2025

HEALTHCAREDIAGNOSTICS & RESEARCH

About Neogenomics Inc

Company Overview

No company information available
View news mentioning NEO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/108832

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime